Donepezil EG 5 mg film-coat. tabl. Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

donepezil eg 5 mg film-coat. tabl.

eg sa-nv - donepezil hydrochloride 5 mg - eq. donepezil 4,56 mg - film-coated tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil

Donepezil Krka 5 mg film-coat. tabl. Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

donepezil krka 5 mg film-coat. tabl.

krka d.d. novo mesto d.d. - donepezil hydrochloride 5 mg - eq. donepezil 4,56 mg - film-coated tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil

Donepezil Sandoz 5 mg film-coat. tabl. Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

donepezil sandoz 5 mg film-coat. tabl.

sandoz sa-nv - donepezil hydrochloride 5 mg - film-coated tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil

Donepezil Sandoz 5 mg orodisp. tabl. Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

donepezil sandoz 5 mg orodisp. tabl.

sandoz sa-nv - donepezil hydrochloride 5 mg - orodispersible tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil

Donepezil Teva 5 mg orodisp. tabl. Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

donepezil teva 5 mg orodisp. tabl.

teva pharma belgium sa-nv - donepezil hydrochloride 5 mg - eq. donepezil 4,56 mg - orodispersible tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil

Donepezil Teva 5 mg film-coat. tabl. Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

donepezil teva 5 mg film-coat. tabl.

teva pharma belgium sa-nv - donepezil hydrochloride 5 mg - eq. donepezil 4,56 mg - film-coated tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil

DONEPEZIL HYDROCHLORIDE- donepezil hydrochloride tablet Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

donepezil hydrochloride- donepezil hydrochloride tablet

mckesson corporation dba sky packaging - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 5 mg - donepezil hydrochloride tablets are indicated for the treatment of dementia of the alzheimer's type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer's disease. donepezil hydrochloride is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. risk summary there are no adequate data on the developmental risks associated with the use of donepezil hydrochloride in pregnant women. in animal studies, developmental toxicity was not observed when donepezil was administered to pregnant rats and rabbits during organogenesis, but administration to rats during the latter part of pregnancy and throughout lactation resulted in increased stillbirths and decreased offspring survival at clinically relevant doses [see data ]. in the u.s. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies are 2% to 4% and 15% to 20%, respectively. the background risks of major

DONEPEZIL HYDROCHLORIDE tablet, film coated
DONEPEZIL HYDROCHLORIDE tablet, orally disintegrating Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

donepezil hydrochloride tablet, film coated donepezil hydrochloride tablet, orally disintegrating

unichem pharmaceuticals (usa), inc. - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride is indicated for the treatment of dementia of the alzheimer's type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer's disease. donepezil hydrochloride is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. risk summary there are no adequate data on the developmental risks associated with the use of donepezil hydrochloride in pregnant women. in animal studies, developmental toxicity was not observed when donepezil was administered to pregnant rats and rabbits during organogenesis, but administration to rats during the latter part of pregnancy and throughout lactation resulted in increased stillbirths and decreased offspring survival at clinically relevant doses [see data]. in the u.s. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies are 2% to 4% and 15% to 20%, respectively. the background risks of major birth def

DONEPEZIL HYDROCHLORIDE tablet, extended release Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

donepezil hydrochloride tablet, extended release

avkare - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 23 mg - donepezil hydrochloride tablets are indicated for the treatment of dementia of the alzheimer’s type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer’s disease. donepezil hydrochloride tablets are contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. pregnancy category c: there are no adequate or well-controlled studies in pregnant women. donepezil hydrochloride tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of donepezil to pregnant rats and rabbits during the period of organogenesis did not produce any teratogenic effects at doses up to 16 mg/kg/day (approximately 6 times the maximum recommended human dose [mrhd] of 23 mg/day on a mg/m 2 basis) and 10 mg/kg/day (approximately 7 times the mrhd on a mg/m 2 basis), respectively. oral administration of donepezil (1, 3, 10 mg/kg/day) to rats during late g